Efficacy and tolerability of a teicoplanin-ciprofloxacin combination in severe community-acquired pneumonia. Comparison with ceftriaxone in a multicentre Italian Study

Clinical Drug Investigation

Volumn 14, Issue 5, 1997, Pages 337-345

  Rizzato, Gianfranco ^a,c   Allegra, Luigi ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CIPROFLOXACIN; TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BIOCHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; LIVER TOXICITY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; STOMATITIS; THORAX RADIOGRAPHY; THROMBOCYTOSIS;

EID: 0030703266     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199714050-00001     Document Type: Article

References (39)

1. Berk S. Bacterial pneumonia in the elderly: the observations of Sir William Osler in retrospect. J Am Geriatr Soc 1984; 32: 683-5
2. Schneider E. Infectious diseases in the elderly. Ann Intern Med 1983; 98: 395-400
3. La Croix A, Lipson S, Miles T, et al. Prospective study of pneumonia hospitalisations and mortality of US older people: the rule of chronic conditions, health behavior, and nutritional status. Public Health Rep 1989; 104: 350-60
4. Niederman M, Fein A. Pneumonia in the elderly. Geriatr Clin North Am 1986; 2: 241-68
5. Verghese A, Berk S. Bacterial pneumonia in the elderly. Medicine (Balt) 1983; 62: 271-82
6. Yoshikawa T. Unique aspects of infections in older adults. In: Yoshikawa T, Norman D, editors. Antimicrobial therapy in the elderly patient. New York: Marcel Dekker Inc, 1994: 1-7
7. Bates J, Campbell B, Barron A, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101: 1005-12
8. Marrie TJ, Durant H, Yates L. Community acquired pneumonia requiring hospitalisation: 5-year prospective study. Rev Infect Dis 1989; 11: 586-99
9. Venkatesan P, Gladman J, MacFarlane J, et al. A hospital study of community acquired pneumonia in the elderly. Thorax 1990; 45: 254-8
10. Niederman M, Fein A. Community-acquired pneumonia in the elderly. In: Niederman M, editor. Respiratory infections in the elderly. New York: Raven Press, 1991: 45-72
11. Bentley D. Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment. Gerontology 1984; 30: 297-307
12. Kirtland S, Winterbauer R, Dreis D, et al. A clinical profile of chronic bacterial pneumonia. Report of 115 cases. Chest 1994; 106: 15-22
13. Gleckman R, Bergman N. Bacterial pneumonia: specific diagnosis and treatment of the elderly. Geriatrics 1987; 42: 29-41
14. Gleckman R, Roth R. Community acquired bacterial pneumonia in the elderly. Pharmacotherapy 1984; 4: 81-8
15. Krieger B, Golden A, Silverman R, et al. Bacteriology, associated conditions and outcome of nursing home acquired pneumonia. Chest 1994; 106 Suppl.: 79S
16. Woodhead M, Radvan J, MacFarlane J. Adult community acquired staphylococcal pneumonia in the antibiotic era: a review of 61 cases. Q J Med 1987; 64: 783-90
17. Yoshikawa T. Empiric antimicrobial therapy. In: Yoshikawa T, Norman D, editors. Antimicrobial therapy in the elderly patient. New York: Marcel Dekker Inc, 1994: 469-77
18. Esposito A. Pneumonia in the elderly. In: Pennington J, editor. Respiratory infections. Diagnosis and management. New York: Raven Press, 1994: 257-74
19. Woodhead M. Management of pneumonia. Respir Med 1992; 86: 459-69
20. Woodhead M. Pneumonia in the elderly. J Antimicrob Chemother 1994; 34 Suppl. A: 85-92
21. Davis A, Jolley A. Antimicrobial therapy of community acquired chest infections. J Antimicrob Chemother 1992; 29: 1-8
22. Wood C. Treatment of severe pneumonia with ciprofloxacin or imipenem [letter]. Antimicrob Agents Chemother 1994; 38: 1871-2
23. Fink M, Snydman D, Niederman N, et al. Treatment of severe pneumonia with ciprofloxacin or imipenem [letter, author's reply]. Antimicrob Agents Chemother 1994; 38: 1871-2
24. Wood M. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209-22
25. Ito A, Odagiri S, Sumitomo M, et al. Dose-finding study of teicoplanin in respiratory infections caused by Staphylococcus aureus. Chemotherapy (Tokyo) 1993; 41 Suppl. 2: 126-33
26. Matsumoto F, Sakurai I, Imai T, et al. Basic and clinical studies on teicoplanin. Chemotherapy (Tokyo) 1993; 41 Suppl. 2: 178-84
27. Watanabe A, Honda Y, Tokue Y, et al. In vitro antimicrobial activity of teicoplanin in respiratory infections caused by Gram-positive cocci. Chemotherapy (Tokyo) 1993; 41 Suppl. 2: 167-72
28. Amaducci S, Rosina R, Pugnetti P, et al. Efficacy and safety of teicoplanin in lower respiratory tract infections bacteriologically diagnosed by fiberoptic bronchoscopy aspirate cultures. In: Gruneberg R, editor. Teicoplanin: further European experience. Royal Society of Medicine Services Limited, London: 1990
29. Amaducci S, Barbieri D, Cogo R, et al. Valutazione comparativa di trattamenti antibiotici empirici in pazienti in insufficienza respiratoria cronica con riacutizzazione infettiva bronchiale. Antibioticoterapia per la pratica 1992; 3: 63-70
30. Gialdroni Grassi G, Bianchi L. Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch Chest Dis 1995; 50: 21-7
31. Woodhead M. Empirical antibiotic therapy and lower respiratory tract infections: European guidelines and current practices. Monaldi Arch Chest Dis 1995; 50: 472-6
32. Niederman M, Bass J, Campbell D, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Official ATS statement. Am Rev Respir Dis 1993; 148: 1418-26
33. Brown R. Community-acquired pneumonia: diagnosis and therapy of older adults. Geriatrics 1993; 48: 43-50
34. Wilson A, Gruneberg R, Neu H. Dosage recommendations for teicoplanin. J Antimicrob Chemother 1993; 32: 792-6
35. Watt B. Interaction of teicoplanin with other antimicrobial agents against Gram positive aerobes. J Antimicrob Chemother 1989; 23: 657-8
36. Georgopoulos A, Breyer S, Czejca N, et al. Activity of teicoplanin alone and in combination. J Chemother 1989; 1 Suppl. 4: 204-6
37. Schito G, Debbia E, Marchese A, et al. Epidemiologia delle resistenze nei patogeni Gram positivi. Atti del 18° Congresso della Società Italiana di Chemioterapia 1993; 191-2
38. Montanari G, Magliano E, Fanti D, et al. Attuali resistenze agli antibiotici dei ceppi clinici di stafilococco isolati da colture di escreato. Giorn It Mal Tor 1993; 47: 23-5
39. Huchon G, Gialdroni Grassi G, Leophonte P, et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996; 9: 1590-5